
|Videos|January 19, 2022
Future Studies and Implications for Dupilumab in Atopic Dermatitis
Future studies are necessary to continue evaluating the true benefits of dupilumab in conditions like atopic dermatitis.
Advertisement
Pharmacy Times spoke with Dr. Peter Lio, assistant professor of dermatology & pediatrics at Northwestern University Feinberg School of Medicine, about dupilumab associated Ocular Surface Disease in patients with atopic dermatitis.
Dr. Lio discussed how this approach has been different than previous studies about atopic dermatitis/conjunctivitis and future studies that are needed for dupilumab.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades
2
Psychiatric Pharmacists Take a Larger Role in Substance Use Disorder Care
3
Aspirin Dosage and Decision-Making: What Pharmacists Should Know
4
Expanding Access to MOUD: The Psychiatric Pharmacist’s Role in Optimization
5












































































































































































































